WWW.KONF.X-PDF.RU
- , ,
 


Pages:     | 1 |   ...   | 6 | 7 ||

, 03.02.02 ...

-- [ 8 ] --

211. Luoh S.M., McGregor M.W., Hinshaw V.S. Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses // J Virol. 1992. V. 66. 2. p. 1066-1073.

212. Maassab H.F., Heilman C.A., Herlocher M.L. Cold-adapted influenza viruses for use as live vaccines for man // Adv Biotechnol Processes. 1990. V. 14. . p. 203-242.

213. Maassab H.F., Kendal A.P., Davenport F.M. Hybrid formation of influenza virus at 25 // Proc Soc Exp Biol Med. 1972. V. 139. 3. p. 768-773.

214. Maines T.R., Lu X.H., Erb S.M., Edwards L., Guarner J., Greer P.W., Nguyen D.C., Szretter K.J., Chen L.M., Thawatsupha P., Chittaganpitch M., Waicharoen S., Nguyen D.T., Nguyen T., Nguyen H.H., Kim J.H., Hoang L.T., Kang C., Phuong L.S., Lim W., Zaki S., Donis R.O., Cox N.J., Katz J.M., Tumpey T.M. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals // J Virol. 2005. V. 79. 18. p. 11788Mani I., Singh V., Chaudhary D.K., Somvanshi P., Negi M.P. Codon optimization of the major antigen encoding genes of diverse strains of influenza a virus // Interdiscip Sci. 2011. V. 3.

1. p. 36-42.

216. Martin J., Wharton S.A., Lin Y.P., Takemoto D.K., Skehel J.J., Wiley D.C., Steinhauer D.A.

Studies of the binding properties of influenza hemagglutinin receptor-site mutants // Virology.

1998. V. 241. 1. p. 101-111.

217. Martin K.,Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import // Cell. 1991. V. 67. 1. p. 117-130.

218. Martin W.J., Ellman L., Green I., Benacerraf B. Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs // J Exp Med. 1970. V. 132. 6. p. 1259-1266.

219. Matrosovich M., Gao P., Kawaoka Y. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host // J Virol. 1998.

V. 72. 8. p. 6373-6380.

220. Matrosovich M., Matrosovich T., Carr J., Roberts N.A., Klenk H.D. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors // J Virol. 2003. V. 77. 15. p. 8418-8425.

221. Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., Donatelli I., Kawaoka Y. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals // J Virol. 2000. V.

74. 18. p. 8502-8512.

222. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium // J Virol. 2004. V. 78. 22. p. 12665-12667.

223. Mazanec M.B., Coudret C.L., Fletcher D.R. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies // J Virol. 1995. V. 69. 2. p. 1339-1343.

224. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza // N Engl J Med. 1983. V. 309. 1. p. 13-17.

225. Medeiros R., Escriou N., Naffakh N., Manuguerra J.C., van der Werf S. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes // Virology. 2001. V. 289. 1. p. 74-85.

226. Merten O.W., Hannoun C., Manuguerra J.C., Ventre F., Petres S. Production of influenza virus in cell cultures for vaccine preparation // Adv Exp Med Biol. 1996. V. 397. . p. 141Mochalova L., Gambaryan A., Romanova J., Tuzikov A., Chinarev A., Katinger D., Katinger H., Egorov A., Bovin N. Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs // Virology. 2003.

V. 313. 2. p. 473-480.

228. Morishita T., Kobayashi S., Miyake T., Ishihara Y., Nakajima S., Nakajima K. Host-specific hemagglutination of influenza A (H1N1) virus // Microbiol Immunol. 1993. V. 37. 8.

p. 661-665.

Moscona A. Neuraminidase inhibitors for influenza // N Engl J Med. 2005. V. 353. 229.

13. p. 1363-1373.

230. Mueller M., Renzullo S., Brooks R., Ruggli N., Hofmann M.A. Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes // PLoS One. 2010. V. 5. 2. p. e9097.

231. Mueller S., Coleman J.R., Papamichail D., Ward C.B., Nimnual A., Futcher B., Skiena S., Wimmer E. Live attenuated influenza virus vaccines by computer-aided rational design // Nat Biotechnol. 2010. V. 28. 7. p. 723-726.

232. Mueller S., Papamichail D., Coleman J.R., Skiena S., Wimmer E. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity // J Virol. 2006. V. 80. 19. p. 9687Munoz E.T.,Deem M.W. Epitope analysis for influenza vaccine design // Vaccine. 2005. 233.

V. 23. 9. p. 1144-1148.

234. Murakami Y., Nerome K., Yoshioka Y., Mizuno S., Oya A. Difference in growth behavior of human, swine, equine, and avian influenza viruses at a high temperature // Arch Virol. 1988.

V. 100. 3-4. p. 231-244.

235. Murphy B.R., Chalhub E.G., Nusinoff S.R., Kasel J., Chanock R.M. Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man // J Infect Dis. 1973. V. 128. 4. p. 479-487.

236. Murphy B.R.,Clements M.L. The systemic and mucosal immune response of humans to influenza A virus // Curr Top Microbiol Immunol. 1989. V. 146. p. 107-116.

237. Muthumani K., Lankaraman K.M., Laddy D.J., Sundaram S.G., Chung C.W., Sako E., Wu L., Khan A., Sardesai N., Kim J.J., Vijayachari P., Weiner D.B. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus // Vaccine. 2008. V. 26. 40. p. 5128-5134.

238. Nagarajan U.M., O'Connell C., Rank R.G. Molecular characterization of guinea - pig (Cavia porcellus) CD8alpha and CD8beta cDNA // Tissue Antigens. 2004. V. 63. 2. p. 184Nakada S., Creager R.S., Krystal M., Palese P. Complete nucleotide sequence of the influenza C/California/78 virus nucleoprotein gene // Virus Res. 1984. V. 1. 6. p. 433-441.

240. Nakamura Y., Gojobori T., Ikemura T. Codon usage tabulated from international DNA sequence databases: status for the year 2000 // Nucleic Acids Res. 2000. V. 28. 1. p.

292.

Nayak D.P., Hui E.K., Barman S. Assembly and budding of influenza virus // Virus Res. 241.

2004. V. 106. 2. p. 147-165.

242. Newhouse E.I., Xu D., Markwick P.R., Amaro R.E., Pao H.C., Wu K.J., Alam M., McCammon J.A., Li W.W. Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: a molecular dynamics perspective // J Am Chem Soc. 2009. V. 131. 47. p. 17430-17442.

243. Ng A.K., Wang J.H., Shaw P.C. Structure and sequence analysis of influenza A virus nucleoprotein // Sci China C Life Sci. 2009. V. 52. 5. p. 439-449.

244. Nobusawa E., Ishihara H., Morishita T., Sato K., Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides // Virology. 2000. V. 278. 2. p. 587-596.

245. Noda T., Sagara H., Yen A., Takada A., Kida H., Cheng R.H., Kawaoka Y. Architecture of ribonucleoprotein complexes in influenza A virus particles // Nature. 2006. V. 439. 7075. p. 490-492.

246. O'Neill R.E., Jaskunas R., Blobel G., Palese P., Moroianu J. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import // J Biol Chem. 1995. V. 270. 39. p. 22701-22704.

247. O'Neill R.E., Talon J., Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins // EMBO J. 1998. V. 17. 1. p. 288-296.

248. Okuno Y., Tanaka K., Baba K., Maeda A., Kunita N., Ueda S. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system // J Clin Microbiol. 1990.

V. 28. 6. p. 1308-1313.

OptimumGene - Codon Optimization. Available at:

249.

http://www.genscript.com/codon_opt.html (Accessed 22 November 2013)

250. Outlaw M.C.,Dimmock N.J. IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells // Virology. 1993. V. 195. 2. p. 413-421.

251. Padilla-Carlin D.J., McMurray D.N., Hickey A.J. The guinea pig as a model of infectious diseases // Comp Med. 2008. V. 58. 4. p. 324-340.

252. Palese P., Tobita K., Ueda M., Compans R.W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase // Virology. 1974. V. 61. 2. p. 397-410.

253. Palker T., Kiseleva I., Johnston K., Su Q., Toner T., Szymkowiak C., Kwan W.S., Rubin B., Petrukhin L., Wlochowski J., Monteiro J., Kraiouchkine N., DiStefano D., Rudenko L., Shaw A., Youil R. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants // Virus Res. 2004. V. 105. 2. p. 183-194.

254. Pappas C., Viswanathan K., Chandrasekaran A., Raman R., Katz J.M., Sasisekharan R., Tumpey T.M. Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957 // PLoS One. 2010. V. 5. 6. p. e11158.

255. Pawar S.D., Parkhi S.S., Koratkar S.S., Mishra A.C. Receptor specificity and erythrocyte binding preferences of avian influenza viruses isolated from India // Virol J. 2012. V. 9. p. 251.

256. Peetermans J. Live influenza virus vaccines and preparation thereof. 1976: United States Patent.

Peitsch M. Protein modeling by E-mail // Bio/technology. 1995. V. 13. p. 658-660.

257.

258. Petukhova G., Naikhin A., Chirkova T., Donina S., Korenkov D., Rudenko L. Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated

lymphoid tissue (NALT) separation method // Vaccine. 2009. V. 27. 19. p. 2580Phair J.P., Kauffman C.A., Jennings R., Potter C.W. Influenza virus infection of the guinea pig:

immune response and resistance // Med Microbiol Immunol. 1979. V. 165. 4. p.

241-254.

260. Pierce B., Tong W., Weng Z. M-ZDOCK: a grid-based approach for Cn symmetric multimer docking // Bioinformatics. 2005. V. 21. 8. p. 1472-1478.

261. Portela A., Digard P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication // J Gen Virol. 2002. V. 83. Pt 4. p. 723-734.

Portela A., Zurcher T., Nieto A., Ortin J. Replication of orthomyxoviruses // Adv Virus Res. 262.

1999. V. 54. p. 319-348.

263. Potter C.W. Chronicle of influenza pandemics. In: Nicholson K.G., Webster K.G., Hay A, eds.

Textbook of Influenza. Oxford, UK. Blackwell Science. 1998. p. 3-18.

264. Potter C.W., ed. Influenza. Perspectives in medical virology. Vol. 7. 2002, Gulf Professional Publishing. 237 p.

265. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man // Br Med Bull. 1979. V. 35. 1. p. 69-75.

266. Prabhu N., Prabakaran M., Ho H.T., Velumani S., Qiang J., Goutama M., Kwang J.

Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection // J Virol. 2009. V. 83. 6. p. 2553-2562.

267. Prat Y., Fromer M., Linial N., Linial M. Codon usage is associated with the evolutionary age of genes in metazoan genomes // BMC Evol Biol. 2009. V. 9. . p. 285.

268. Pritchett T.J., Paulson J.C. Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin // J Biol Chem. 1989. V. 264. 17. p. 9850Raab D., Graf M., Notka F., Schodl T., Wagner R. The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization // Syst Synth Biol. 2010. V. 4. 3. p. 215-225.

270. Ramakrishna L., Anand K.K., Mohankumar K.M., Ranga U. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization // J Virol. 2004. V. 78. 17. p. 9174-9189.

Rappuoli R., Del Giudice G. Influenza Vaccines for the Future. 2010. Springer Science & 271.

Business Media. 460 p.

272. Raymond F.L., Caton A.J., Cox N.J., Kendal A.P., Brownlee G.G. Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype // Nucleic Acids Res. 1983. V. 11. 20. p. 7191-7203.

273. Reading P.C., Job E.R., Tate M.D., et al. Inhibition of influenza viruses by proteins of the innate immune system // In: Options for the control of influenza VI. Toronto, Ontario, Canada.

17-23 June 2007. 2007. p. 489-491.

274. Reading P.C., Morey L.S., Crouch E.C., Anders E.M. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice // J Virol. 1997. V. 71. 11. p. 8204-8212.

Reed L., Muench H. A simple method of estimating 50 % endpoints // Amer J Hygiene. 275.

1938. V. 27. p. 493-497.

276. Robb N.C., Smith M., Vreede F.T., Fodor E. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome // J Gen Virol. 2009. V. 90. Pt 6. p. 1398-1407.

277. Robertson J.S., Bootman J.S., Newman R., Oxford J.S., Daniels R.S., Webster R.G., Schild G.C. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus // Virology. 1987. V. 160. 1. p. 31-37.

278. Rogers G.N., Paulson J.C., Daniels R.S., Skehel J.J., Wilson I.A., Wiley D.C. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity // Nature. 1983. V. 304. 5921. p. 76-78.

279. Rogers G.N., Pritchett T.J., Lane J.L., Paulson J.C. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants // Virology. 1983. V. 131. 2. p. 394-408.

280. Roychoudhury S.,Mukherjee D. A detailed comparative analysis on the overall codon usage pattern in herpesviruses // Virus Res. 2010. V. 148. 1-2. p. 31-43.

281. Rudenko L., Desheva J., Korovkin S., Mironov A., Rekstin A., Grigorieva E., Donina S., Gambaryan A., Katlinsky A. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials) // Influenza Other Respi Viruses. 2008. V. 2. 6. p. 203-209.

282. Rudenko L., Isakova-Sivak I., Donina S. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus // Vaccine. 2013. V. 31. 42. p. 4702-4705.

283. Rudenko L., van den Bosch H., Kiseleva I., Mironov A., Naikhin A., Larionova N., Bushmenkov D. Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries // Vaccine. 2011. V. 29 Suppl 1. . p. A40-4.

284. Saito T., Taylor G., Laver W.G., Kawaoka Y., Webster R.G. Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase // J Virol. 1994. V. 68. 3. p. 1790-1796.

285. Schnell J.R., Chou J.J. Structure and mechanism of the M2 proton channel of influenza A virus // Nature. 2008. V. 451. 7178. p. 591-595.

286. Schoch C., Blumenthal R. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion // J Biol Chem. 1993. V. 268. 13. p. 9267-9274.

287. Scholtissek C., Rohde W., Von Hoyningen V., Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2 // Virology. 1978. V. 87. 1. p. 13-20.

288. Schulze I.T. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin // J Infect Dis. 1997. V. 176 Suppl 1. . p. S24-8.

289. Schwartz B.D., Kask A.M., Paul W.E., Shevach E.M. Structural characteristics of the alloantigens determined by the major histocompatibility complex of the guinea pig // J Exp Med. 1976. V. 143. 3. p. 541-58.

290. Schwartz B.D., Kask A.M., Shevach E.M. The guinea pig MHC: functional significance and structural characterization // Cold Spring Harb Symp Quant Biol. 1977. V. 41 Pt 1. . p. 367-403.

291. Sha B., Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1 // Nat Struct Biol. 1997. V. 4. 3. p. 239-244.

292. Shevach E.M., Schwartz B.D. Overview of the structure and function of the major histocompatibility complex of the guinea pig // Fed Proc. 1977. V. 36. 9. p. 2260Shinya K., Ebina M., Yamada S., Ono M., Kasai N., Kawaoka Y. Avian flu: influenza virus receptors in the human airway // Nature. 2006. V. 440. 7083. p. 435-436.

294. Shinya K., Hamm S., Hatta M., Ito H., Ito T., Kawaoka Y. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice // Virology. 2004. V. 320. 2. p. 258-266.

295. Shtyrya Y., Mochalova L., Voznova G., Rudneva I., Shilov A., Kaverin N., Bovin N.

Adjustment of receptor-binding and neuraminidase substrate specificities in avian-human reassortant influenza viruses // Glycoconj J. 2009. V. 26. 1. p. 99-109.

Shu-Yi F., Tanaka T., Goto H., Tobita K. // Acta Virol. 1983. V. 27. 1. p. 21-26.

297. Skehel J.J.,Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin // Annu Rev Biochem. 2000. V. 69. p. 531-69.

298. Smorodintsev A.A., Alexandrova G.A., Chalkina O.M., Selivanov A.A. Experience in the

development of live vaccines against influenza and influenza-like respiratory infections // In:

Applied Virology (1965), (1st Annual Symposium, Boca Raton, Florida, 1964, edited by M.

Saunders, E.H. Lennette) Sheboygan, Wisconsin. 1965. p. 142.

299. Sriwilaijaroen N.,Suzuki Y. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus // Proc Jpn Acad Ser B Phys Biol Sci. 2012. V. 88. 6. p. 226-249.

300. Stanekova Z.,Vareckova E. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development // Virol J. 2010. V. 7. p. 351.

301. Steel J., Lowen A.C., Wang T.T., Yondola M., Gao Q., Haye K., Garcia-Sastre A., Palese P.

Influenza virus vaccine based on the conserved hemagglutinin stalk domain // MBio. 2010. V. 1. 1.

302. Stephenson I., Wood J.M., Nicholson K.G., Zambon M.C. Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin // J Med Virol. 2003. V. 70. 3. p. 391-398.

303. Stieneke-Grober A., Vey M., Angliker H., Shaw E., Thomas G., Roberts C., Klenk H.D., Garten W. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease // EMBO J. 1992. V. 11. 7. p. 2407-2414.

304. Stittelaar K.J., Veldhuis Kroeze E.J., Rudenko L., Dhere R., Thirapakpoomanunt S., Kieny M.P., Osterhaus A.D. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets // Vaccine. 2011. V. 29. 49. p. 9265-9270.

305. Stitz L., Schmitz C., Binder D., Zinkernagel R., Paoletti E., Becht H. Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection // J Gen Virol. 1990. V. 71 ( Pt 5). p. 1169-1179.

Stuart-Harris C.H. Influenza Virus Infection of Rats and Guinea-pigs // Br J Exp Pathol. 306.

1937. V. 18. 6. p. 485-492.

307. Subbarao E.K., Park E.J., Lawson C.M., Chen A.Y., Murphy B.R. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine // J Virol. 1995. V. 69. 10. p. 5969-5977.

308. Suguitan A.L., Jr., McAuliffe J., Mills K.L., Jin H., Duke G., Lu B., Luke C.J., Murphy B., Swayne D.E., Kemble G., Subbarao K. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets // PLoS Med. 2006. V. 3. 9. p. e360.

309. Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses // Biol Pharm Bull. 2005. V. 28. 3. p. 399-408.

310. Swain S.L., Agrewala J.N., Brown D.M., Jelley-Gibbs D.M., Golech S., Huston G., Jones S.C., Kamperschroer C., Lee W.H., McKinstry K.K., Roman E., Strutt T., Weng N.P. CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza // Immunol Rev. 2006. V. 211. p. 8-22.

311. Sweet C., Collie M.H., Toms G.L., Smith H. The pregnant guinea-pig as a model for studying influenza virus infection in utero: infection of foetal tissues in organ culture and in vivo // Br J Exp Pathol. 1977. V. 58. 2. p. 133-139.

312. Sylte M.J.,Suarez D.L. Influenza neuraminidase as a vaccine antigen // Curr Top Microbiol Immunol. 2009. V. 333. p. 227-241.

313. Takemae N., Ruttanapumma R., Parchariyanon S., Yoneyama S., Hayashi T., Hiramatsu H., Sriwilaijaroen N., Uchida Y., Kondo S., Yagi H., Kato K., Suzuki Y., Saito T. Alterations in receptor-binding properties of swine influenza viruses of the H1 subtype after isolation in embryonated chicken eggs // J Gen Virol. 2010. V. 91. Pt 4. p. 938-948.

314. Tamura S., Tanimoto T., Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines // Jpn J Infect Dis. 2005. V. 58. 4. p. 195-207.

315. Tats A., Tenson T., Remm M. Preferred and avoided codon pairs in three domains of life // BMC Genomics. 2008. V. 9. p. 463.

316. Tenbusch M., Grunwald T., Niezold T., Storcksdieck Genannt Bonsmann M., Hannaman D., Norley S., Uberla K. Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice // Vaccine. 2010. V. 28. 19. p. 3273-3277.

317. Thangavel R.R.,Bouvier N.M. Animal models for influenza virus pathogenesis, transmission, and immunology // J Immunol Methods. 2014. V. 410C. p. 60-79.

318. Thoennes S., Li Z.N., Lee B.J., Langley W.A., Skehel J.J., Russell R.J., Steinhauer D.A.

Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion // Virology. 2008. V. 370. 2. p. 403-414.

319. Thomas P.G., Keating R., Hulse-Post D.J., Doherty P.C. Cell-mediated protection in influenza infection // Emerg Infect Dis. 2006. V. 12. 1. p. 48-54.

320. Tokuoka M., Tanaka M., Ono K., Takagi S., Shintani T., Gomi K. Codon optimization increases steady-state mRNA levels in Aspergillus oryzae heterologous gene expression // Appl Environ Microbiol. 2008. V. 74. 21. p. 6538-6546.

321. Tyrrell D.A.,Beare A.S. Some studies on the selection and efficiency of live influenza vaccine viruses // Bull World Health Organ. 1969. V. 41. 3. p. 581-584.

322. Van der Laan J.W., Herberts C., Lambkin-Williams R., Boyers A., Mann A.J., Oxford J.

Animal models in influenza vaccine testing // Expert Rev Vaccines. 2008. V. 7. 6. p. 783-793.

323. Van Hoeven N., Belser J.A., Szretter K.J., Zeng H., Staeheli P., Swayne D.E., Katz J.M., Tumpey T.M. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding // J Virol.

2009. V. 83. 7. p. 2851-2861.

324. Van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals // Am J Pathol. 2007. V. 171. 4. p. 1215-1223.

325. Varghese J.N., Laver W.G., Colman P.M. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution // Nature. 1983. V. 303. 5912. p. 35-40.

326. Velumani S., Ho H.T., He F., Musthaq S., Prabakaran M., Kwang J. A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses // PLoS One. 2011. V. 6. 6. p. e20737.

327. Wagner R., Matrosovich M., Klenk H.D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections // Rev Med Virol. 2002. V. 12. 3. p.

159-166.

328. Wang C.C., Chen J.R., Tseng Y.C., Hsu C.H., Hung Y.F., Chen S.W., Chen C.M., Khoo K.H., Cheng T.J., Cheng Y.S., Jan J.T., Wu C.Y., Ma C., Wong C.H. Glycans on influenza hemagglutinin affect receptor binding and immune response // Proc Natl Acad Sci U S A. 2009. V. 106. 43. p. 18137-18142.

329. Wang Q., Tian X., Chen X., Ma J. Structural basis for receptor specificity of influenza B virus hemagglutinin // Proc Natl Acad Sci U S A. 2007. V. 104. 43. p. 16874-16879.

330. Wang R., Song A., Levin J., Dennis D., Zhang N.J., Yoshida H., Koriazova L., Madura L., Shapiro L., Matsumoto A., Mikayama T., Kubo R.T., Sarawar S., Cheroutre H., Kato S.

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein // Antiviral Res. 2008. V. 80. 2. p. 168-177.

331. Wang S., Taaffe J., Parker C., Solorzano A., Cao H., Garcia-Sastre A., Lu S. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codonoptimized HA DNA vaccines // J Virol. 2006. V. 80. 23. p. 11628-11637.

332. Wang W., Anderson C.M., De Feo C.J., Zhuang M., Yang H., Vassell R., Xie H., Ye Z., Scott D., Weiss C.D. Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2 // PLoS Pathog.

2011. V. 7. 6. p. e1002081.

333. Wang W., Lu B., Zhou H., Suguitan A.L., Jr., Cheng X., Subbarao K., Kemble G., Jin H.

Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets // J Virol. 2010. V. 84. 13. p. 6570Wang W., Riedel K., Lynch P., Chien C.Y., Montelione G.T., Krug R.M. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids // RNA. 1999. V. 5. 2. p. 195-205.

335. Wang Y.F., Chang C.F., Chi C.Y., Wang H.C., Wang J.R., Su I.J. Characterization of glycan binding specificities of influenza B viruses with correlation with hemagglutinin genotypes and clinical features // J Med Virol. 2012. V. 84. 4. p. 679-685.

336. Wareing M.D., Marsh G.A., Tannock G.A. Preparation and characterisation of attenuated coldadapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain // Vaccine. 2002. V. 20. 16. p. 2082-2090.

337. Webby R.J., Perez D.R., Coleman J.S., Guan Y., Knight J.H., Govorkova E.A., McClain-Moss

L.R., Peiris J.S., Rehg J.E., Tuomanen E.I., Webster R.G. Responsiveness to a pandemic alert:

use of reverse genetics for rapid development of influenza vaccines // Lancet. 2004. V.

363. 9415. p. 1099-1103.

338. Webster R.G., Brown L.E., Laver W.G. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies // Virology. 1984. V. 135. 1. p. 30-42.

339. Webster R.G., Reay P.A., Laver W.G. Protection against lethal influenza with neuraminidase // Virology. 1988. V. 164. 1. p. 230-237.

340. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., Wiley D.C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid // Nature. 1988. V. 333. 6172. p. 426-431.

341. Welsh R.M., Selin L.K., Szomolanyi-Tsuda E. Immunological memory to viral infections // Annu Rev Immunol. 2004. V. 22. p. 711-743.

342. Whittaker G., Bui M., Helenius A. The role of nuclear import and export in influenza virus infection // Trends Cell Biol. 1996. V. 6. 2. p. 67-71.

343. Whittle J.R., Zhang R., Khurana S., King L.R., Manischewitz J., Golding H., Dormitzer P.R., Haynes B.F., Walter E.B., Moody M.A., Kepler T.B., Liao H.X., Harrison S.C. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin // Proc Natl Acad Sci U S A. 2011. V. 108. 34. p. 14216-14221.

344. WHO Technical Report Series. No. 977, 2013. Annex 4. Recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal

administration. Avaible at:

http://www.who.int/entity/biologicals/areas/vaccines/influenza/TRS_977_Annex_4.pdf.

Accessed on 1.07.2014.

345. WHO/IVB/09.05. Global pandemic influenza action plan to increase vaccine supply: progress report 2006-2008. Accessed 1.10.2013 on http://whqlibdoc.who.int/hq/2009/WHO_IVB_09.05_eng.pdf.

346. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus // Annu Rev Biochem. 1987. V. 56. p. 365-394.

347. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution // Nature. 1981. V. 289. 5796. p. 366-373.

348. Woolpert O.C., Gallagher F.W., Rubinstein L., Hudson N.P. Propagation of the Virus of Human Influenza in the Guinea Pig Fetus // J Exp Med. 1938. V. 68. 3. p. 313-324.

349. Wright P.F., Murphy B.R., Kervina M., Lawrence E.M., Phelan M.A., Karzon D.T. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory // Infect Immun. 1983. V. 40. 3. p. 1092-1095.

350. Wu Y., Tefsen B., Shi Y., Gao G.F. Bat-derived influenza-like viruses H17N10 and H18N11 // Trends Microbiol. 2014. V. 22. 4. p. 183-191.

351. Xu Q., Wang W., Cheng X., Zengel J., Jin H. Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets // J Virol. 2010. V. 84. 10. p. 4936-4945.

352. Xu X., Cox N.J., Bender C.A., Regnery H.L., Shaw M.W. Genetic variation in neuraminidase genes of influenza A (H3N2) viruses // Virology. 1996. V. 224. 1. p. 175-183.

353. Yan J., Corbitt N., Pankhong P., Shin T., Khan A., Sardesai N.Y., Weiner D.B.

Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine // Vaccine. 2011. V. 29. 41. p. 7173-7181.

354. Yan J., Yoon H., Kumar S., Ramanathan M.P., Corbitt N., Kutzler M., Dai A., Boyer J.D., Weiner D.B. Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine // Mol Ther. 2007. V. 15. 2. p. 411-421.

355. Yarchoan R., Murphy B.R., Strober W., Schneider H.S., Nelson D.L. Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells // J Immunol.

1981. V. 127. 6. p. 2588-2594.

356. Yasuda J., Nakada S., Kato A., Toyoda T., Ishihama A. Molecular assembly of influenza virus:

association of the NS2 protein with virion matrix // Virology. 1993. V. 196. 1. p.

249-255.

357. Yewdell J.W.,Gerhard W. Antigenic characterization of viruses by monoclonal antibodies // Annu Rev Microbiol. 1981. V. 35. . p. 185-206.

358. Yoshida R., Igarashi M., Ozaki H., Kishida N., Tomabechi D., Kida H., Ito K., Takada A.

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses // PLoS Pathog. 2009. V. 5. 3. p.

e1000350.

359. Zamarin D., Garcia-Sastre A., Xiao X., Wang R., Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1 // PLoS Pathog. 2005. V. 1. 1. p. e4.

360. Zamarin D., Ortigoza M.B., Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice // J Virol. 2006. V. 80. 16. p. 7976-7983.

361. Zhang J., Pekosz A., Lamb R.A. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins // J Virol. 2000. V. 74. 10. p. 4634-4644.

362. Zhi N., Wan Z., Liu X., Wong S., Kim D.J., Young N.S., Kajigaya S. Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells // J Virol. 2010. V. 84. 24. p. 13059-13062.

363. Zhirnov O.P., Vorobjeva I.V., Saphonova O.A., Poyarkov S.V., Ovcharenko A.V., Anhlan D., Malyshev N.A. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells // J Clin Virol. 2009. V. 45. 4. p. 322-333.

364. Zhu Y., Lu F., Dai Y., Wang X., Tang J., Zhao S., Zhang C., Zhang H., Lu S., Wang S.

Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines // Vaccine. 2010. V. 28. 32. p. 5347-5355.

   

2. , , A//07/09-PR8 //134/17/57 (H2N2)

   

A/PR/8/34 (H1N1), .

2 //134/17/57 (H2N2).3 5 + .4 A//07/09.

   

4. , (Hoffmann E.

, Stech J., Guan Y., Webster R.G., et al. Universal primer set for the full-length amplification of all influenza A viruses // Arch Virol. 2001. V. 146. 12. - p. 2275-2289)

   

:

.., .., .., .., .. 1.

/17/ / 95/ 4 (H3N2) . 2128223 07.05.1997.

.., .., .., .., .. 2.

/47/ / 95/ 13 (H3N2) . 2127757 07.05.1997.

.., .., .., .., .. 3.

/17//97/76 (H3N2) . 2159812 15.06.1999 . 2000. .. .

......- . . , 2001: .

.., .., .., .., .. 5.

/47//97/14 (H3N2) . 2159809 25.05.1999 . 2000.- 33.

.., .., .., .. 6.

/17//99/242(H3N2) . 2248394 20.03.2005 .

.., .., .., .. 7.

/47//99/234 (H3N2) . 2266329 20.12.2005 .

.., .., .., .. 8.

/17//03/8 (H3N2) . 2285723 20.10.2006 .

.., .., .., .. 9.

/17//04/6 (H3N2) . 2315101 20.07.2007 .., .., .. /17/ 10.

/04/71 (H3N2) . 2307162 27.09.2007 .., .., .., .. , 11.

147, ( /17//04/11 H3N2). 2319744 19.04.06. . 2008.8.

.., .., .., .. 12.

/17//07/1 (H3N2) . 2416640 11.01.10. . 2011.11.

.., .., .. 13.

. (/17//09/87 (H3N2).

2464311. 20.10.2012. 24.05.2011. . 20.10.2012 . 29.

.., .., .., . H/1/2/17 14.

. . - 833260 1978.

.. . 15.

. ... 1983, : .

.., .., .., .., .., 16.

.., . 17/42/3 (H3N2), . . - 1003539 28.05.1981.

.., .., .., .., .., 17.

.., . . . 2003. 48 (4): 26-29.

.., 18.

. . ...

. 1989: .

.., .., .., . 47/ 19.

(3N2) . - 1655985 15.12.91.

.., .., .., .. 20.

/17//94/ 1 (H3N2) . 2110277 30.05.1996.

.., .., .. /47/ /94/1 (H3N2) 21.

. 2110278 30.05.1996.

.., .., .., . /17//93/3/5 22.

(H3N2) . 2077582 29.12.1994.

.., .., .., .., .. /17/ 23.

/92/4 (H3N2) .

2078818 30.09.1994.

.., .., .., .. 24.

/47//92/3 (H3N2) . 2078820 30.09.1994.

.., .., .. 25.

/17//05/84 (H3N2) . 2340671 13.06.07. . 10.12.2008.34. 2008.

.., .., .., .., .., 26.

.., . 47/7/2 (H3N2), . . - 1036739 04.08.1981.

.., .., .., .. 27.

/17//95/29 (H1N1) . 2144955 30.04.1998 . 2000.- 3. 2000.

.., .., .. 28.

/47//96/7/7 (H1N1) . 2151185 10.12.1998. . 2000.- 17.

.., .., .., .., .. 29.

/17//95/25 (H1N1) . 2159811 20.05.1999 . 2000. .., .., .., .., .. 30.

/47//95/35 (H1N1) - . 2159810 25.05.1999 . 2000.- 33.

.., .., .., .. 31.

/17/ /99/145 (H1N1) . 2183672 08.12.2000 . 2002. .., .., .., .. 32.

/47/ /99/156 (H1N1) . 2185437 08.12.2000 . 2002.- 20.

.., .., .., .., 33.

/17//07/28 (H1N1) . 2416641 30.12.10. . 2011.11. 2011.

.., .., .., .. 34.

/17/ /06/9 (H1N1) . 2422518 11.01.2010. . 2011.18.

.., .., .., .. 35.

/17//2009/38 (H1N1) . 2413765 16.09.09. . 2011.7.

.., .., .., .., .., 36.

.., . H/32/5 (H1N1). . - 833260 27.08.1979.

.., .., .., .., .., 37.

.., . /47/ A(H1N1) . - 1446925 22.08.88.

.., .., .., . 47/ 38.

(1N1) . - 1632040 01.11.90.

.., .., .., .., .. 39.

/17// 91/ 1/ 3 (H1N1) . 2084524 30.09.1994.

.., .., .., .. /47/ /91/2/6 40.

(H1N1) . 2077581 30.09.1994.

.., .., .., .., .., 41.

.., . 47/25/1 (H1N1), . . - 1036742 04.08.1981.

.., .., .., .. / 60/ 42.

/ 95/ 20 . 2128224 07.05.1997.

.., .., .., .., .. 43.

/60//99/50 . 2215786 19.03.2002 . , 2003 - 31.

.., .., .. 44.

/60//01/22 . 2266329 15.03.2004 .

.., .., .., .. 45.

/60//03/1 . 2307161 09.07.2007 .

.., .., .., .. 46.

/60//04/181 . 2422519 11.01.2010. . 2011.18.

.., .., .., .. 47.

/60//04/898 . 2416639 30.12.10. . 2011.11.

.., .., .., .. 48.

/60//08/83 //60/525/69 . 2422517 28.01.2010. . 2011.18.

.., .., .., .. . /60/32/P 49.

, . - 1731811 10.07.90.

.., .., .., .. //90 (4) 50.

, . 2078819 30.09.1994.



Pages:     | 1 |   ...   | 6 | 7 ||
 

:

: , : 05.18.07 : , , ...

( ) 25.00.36 ( ) - - 201...

- 25.00.25 : ...

03.02.14 2015 ..3 I. . 1.1....

14.02.02 : ...

- 03.02.03 ...

- 03.01.06 ( ) , .. 2014 .....

: 03.02.08 () : , .. 1. ...

, 03.02.08 : ...

ROSA L. 03.02.01 ..., 1. ROSA L. . 2. ROSA L. 2.1. Rosa L. 2.2. Rosa L. 3....

. () 03.02.08 , .. 2015...

: , : 05.18.07 : ,...

5N 03.02.02 ..., . . 20 1. 2. 2.1. 2.2. 2.3. ...

Ȼ 14.01.11 : , .. 2015 1. ...

( ) 03.02.08 ( ) : ...

ROSA L. 03.02.01 ..., 1. ROSA L. . 2. ROSA L. 2.1. Rosa L. 2.2. Rosa L. 3....

( ) : 03.02.08 : ...

IN VITRO 03.02.03 : ...

14.02.02 : ...

QX 06.02.02 , , , : , ...







 
<<     |    
2016 www.konf.x-pdf.ru - - , ,

, .
, , , , 1-2 .